Belgium· BE-AMP-SAM535333-00
Veyvondi 650 IU
A von willebrand factor product containing vonicog alfa, registered in Belgium by Baxalta Innovations. The same ATC class is registered in 11 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Von willebrand factor is registered in 11 of 19 countries.
Countries holding a registration under ATC B02BD10 (von willebrand factor), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Von willebrand factor · ATC B02BD10
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Vonicog Alfa
- Manufacturer
- Baxalta Innovations
- Country
- Belgium (BE)
- ATC code
- B02BD10
- ATC class
- Von Willebrand factor
- Defined daily dose
- 1.5 TSD, E
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
2 interactions on record for von willebrand factor.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Von willebrand factor · interactions on record
2 records
- 2 severe
Most severe, free to view
- CarfilzomibL01XG02severe
- CarfilzomibL01XX45severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Von willebrand factor in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayVeyvondiBaxalta Innovations GmbH
- SwedenVEYVONDI 650 IE Pulver och vätska till injektionsvätska, lösningBaxalta Innovations GmbH
- SwitzerlandVEYVONDI 1300 IE, Pulver und Lösungsmittel zur Herstellung einer InjektionslösungTakeda Pharma AG
- CzechiaVEYVONDIBaxalta Innovations GmbH, Vídeň
- FinlandVeyvondiBaxalta Innovations GmbH
- FranceVEYVONDI 1 300 UI poudre et solvant pour solution injectableBAXALTA INNOVATIONS (AUTRICHE)
- United KingdomVeyvondi 1,300unit powder and solvent for solution for injection vialsTakeda UK Ltd
- IrelandVEYVONDI 1300 IU powder and solvent for solution for injectionBaxalta Innovations GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Veyvondi
- Liechtenstein · Veyvondi
- Norway · Veyvondi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1c05e01c-9210-4123-89b8-a79df1b43450 GET /v1/drugs/1c05e01c-9210-4123-89b8-a79df1b43450?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder and solvent for solution for injection",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Veyvondi 650 IU",
"name_fr": "Veyvondi 650 IU",
"name_nl": "Veyvondi 650 IU",
"amp_code": "SAM535333-00",
"strengths": [
"130.0000"
],
"pack_count": 1,
"substances": [
"Vonicog Alfa",
"Mannitol",
"Polysorbate 80"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Von Willebrand Factor",
"authorisation_numbers": [
"EU/1/18/1298/001"
]
}See everything about von willebrand factor.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.